ArticleBMC infectious diseases2026
Implementation of tuberculosis care cascade among adult people living with HIV registered in anti-retroviral therapy centres in Odisha, India, 2020-2023.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Assessment of the acceptability and usability of an integrated HIV-TB digital portal at anti-retroviral therapy centres in Odisha, India.Public health action · 2026Article
- Mentorship for research on TB in India: a course on Public Health Implementation Strengthening and Operational Research (MPHISOR).Public health action · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIndia bears a significant burden of HIV-tuberculosis co-infections reporting 48,000 cases in 2022. Although a comprehensive national framework exists for managing tuberculosis and tuberculosis preventive treatment among People Living with HIV (PLHIV), implementation gaps persist. We conducted this study to describe the tuberculosis care cascade among newly registered adult PLHIV attending anti-retroviral therapy (ART) centres in Odisha, India.
methodsWe conducted a secondary analysis of programme data from all the 19 anti-retroviral therapy centres across Odisha’s 30 districts. The study included adult PLHIV and newly registered at anti – retroviral therapy centres from April 2020 to March 2023, excluding those with pre-existing tuberculosis during registration, non-residents of Odisha and transferred-out cases. The follow up data was available till March 2024. Data were extracted from two digital platforms i.e., the SOCH (for baseline characteristics, symptomatic screening of tuberculosis − 4s screening, and tuberculosis preventive treatmentr) and Ni-kshay (for type and treatment outcome of tuberculosis) portal which are digital platforms for HIV/AIDS and tuberculosis program in the country. Extracted data was cleaned, coded and analysed.
resultsA total of 4,835 newly registered PLHIV were included out of which data related to 4s screening for tuberculosis was available for only 19.3% (n = 934) individuals. Among 934 for whom the data was available, 4s screening was done among 94.3% (95% CI: 92.6% − 95.7%) i.e. 881 individuals. Among those who were screened for 4s symptoms (n = 881), the positivity for any of 4s symptoms was 18.4% (95% CI: 15.9% − 21.1%). Among those who were eligible for tuberculosis preventive treatment (n = 668), initiation was done among 64.2% (95% CI: 60.5%-67.9%). Overall, 65 PLHIV were diagnosed with tuberculosis from the date of ART registration and till March 2024. Out of which treatment outcome data was available for 61 individuals. Successful treatment outcome was seen in 78.7% adult PLHIV.
conclusionAfter registration at ART centre, symptomatic screening was done for majority of PLHIV but initiation of tuberculosis preventive treatment was less. Data inconsistencies and sub-optimal data entry in the management information system highlights the need for further research for strengthening the system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.